Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

More articles from TRANSLATING IMMUNOLOGY

  • You have accessRestricted access
    Translating JAKs to Jakinibs
    Massimo Gadina, Danielle A. Chisolm, Rachael L. Philips, Iain B. McInness, Paul S. Changelian and John J. O’Shea
    J Immunol 204 (8) 2011-2020; April 15, 2020, doi: https://doi.org/10.4049/jimmunol.1901477
  • You have accessRestricted access
    A 20-Year Journey from Axonal Injury to Neurodegenerative Diseases and the Prospect of Immunotherapy for Combating Alzheimer’s Disease
    Michal Schwartz, Javier M. Peralta Ramos and Hila Ben-Yehuda
    J Immunol 204 (2) 243-250; January 15, 2020, doi: https://doi.org/10.4049/jimmunol.1900844
  • You have accessRestricted access
    Low-Dose IL-2 Therapy in Transplantation, Autoimmunity, and Inflammatory Diseases
    Maryam Tahvildari and Reza Dana
    J Immunol 203 (11) 2749-2755; December 1, 2019, doi: https://doi.org/10.4049/jimmunol.1900733
  • You have accessRestricted access
    T Cell–Activating Bispecific Antibodies in Cancer Therapy
    Asaad Trabolsi, Artavazd Arumov and Jonathan H. Schatz
    J Immunol 203 (3) 585-592; August 1, 2019, doi: https://doi.org/10.4049/jimmunol.1900496
  • You have accessRestricted access
    Discovery of the IL-23/IL-17 Signaling Pathway and the Treatment of Psoriasis
    Jason E. Hawkes, Bernice Y. Yan, Tom C. Chan and James G. Krueger
    J Immunol 201 (6) 1605-1613; September 15, 2018, doi: https://doi.org/10.4049/jimmunol.1800013
  • You have accessRestricted access
    Passive Serum Therapy to Immunomodulation by IVIG: A Fascinating Journey of Antibodies
    Cristina João, Vir Singh Negi, Michel D. Kazatchkine, Jagadeesh Bayry and Srini V. Kaveri
    J Immunol 200 (6) 1957-1963; March 15, 2018, doi: https://doi.org/10.4049/jimmunol.1701271
  • You have accessRestricted access
    Inhibitors of the PD-1 Pathway in Tumor Therapy
    Martin W. LaFleur, Yuki Muroyama, Charles G. Drake and Arlene H. Sharpe
    J Immunol 200 (2) 375-383; January 15, 2018, doi: https://doi.org/10.4049/jimmunol.1701044
  • You have accessRestricted access
    Natalizumab for Multiple Sclerosis: A Case in Point for the Impact of Translational Neuroimmunology
    Afsaneh Shirani and Olaf Stüve
    J Immunol 198 (4) 1381-1386; February 15, 2017, doi: https://doi.org/10.4049/jimmunol.1601358
  • You have accessRestricted access
    From IgE to Omalizumab
    Toshiaki Kawakami and Ulrich Blank
    J Immunol 197 (11) 4187-4192; December 1, 2016, doi: https://doi.org/10.4049/jimmunol.1601476
  • You have accessRestricted access
    Costimulation Blockade in Autoimmunity and Transplantation: The CD28 Pathway
    Andrew B. Adams, Mandy L. Ford and Christian P. Larsen
    J Immunol 197 (6) 2045-2050; September 15, 2016, doi: https://doi.org/10.4049/jimmunol.1601135

Pages

  • Next
  • 1
  • 2
  • 3

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • Public Access
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606